Yaniv Saragosti


[email protected]

Yaniv is a versatile business lawyer who has expertise in domestic and cross-border transactions, private equity and venture capital, as well as general corporate and commercial law. He represents clients in a broad range of transactions, including mergers and acquisitions, corporate finance, corporate reorganizations and joint ventures.

His clients include private and public companies, entrepreneurs, family offices, private equity and venture capital funds, and pension funds.

Yaniv’s private equity and venture capital practice includes fund formation.

He also has significant experience advising private equity firms and strategic buyerswith respect to “add on” and “roll up” acquisition strategies, including in highly regulated industries such as the veterinary sector.

He regularly assists foreign clients interested in expanding into Canada, which includes setting up new Canadian subsidiaries or investing in or acquiring existing Canadian businesses.


  • Alcumus Group Limited in connection with its acquisition of Cognibox.
  • Ingersoll Rand in connection with its acquisition of Maximus.
  • VetStrategy and Groupe Vétérinaire Daubigny in connection with Berkshire Partners’ acquisition of a majority stake in VetStrategy from Imperial Capital.
  • Covea Group, a shareholder of La Capitale, in the context of La Capitale’s merger transaction with SSQ.
  • Groupe Vétérinaire Daubigny in multiple add-on acquisitions of veterinary clinics and hospitals in the Province of Quebec.
  • Panache Ventures in their first fund formation.
  • CiToxLAB Group Inc. in connection with its acquisition of AccelLAB Inc.
  • O'Leary Funds Management LP in connection with the sale of its mutual fund business to Canoe Financial LP.
  • Doris Inc. and its shareholders in connection with the sale of Doris' Canadian, U.S. and Hong Kong business to Gildan Activewear Inc.
  • BDC Venture Capital and Investissement Québec in the context of their investment in White Star Capital.
  • Strides Arcolab Limited in the context of the sale of its Agila Specialties Pharma Corporation business to Mylan Inc.
  • Institutional investors in respect of their investment in iNovia Fund III.

Beyond Our Walls

Professional Involvement

  • Member, Canadian Bar Association
  • Member, Law Society of Upper Canada
  • Member, Barreau du Québec

Awards & Recognitions

  • Recognized in the 2024 edition (and since 2022) of The Best Lawyers in Canada (Venture Capital Law).
  • Recognized in the 2023 edition (and since 2021) of the Canadian Legal Lexpert Directory (Corporate Mid-Market)
  • Recognized in the 2023 edition (and since 2022) of Lexpert Special Edition: Technology & Health Sciences
  • Recognized in the 2022 edition of Lexpert Special Edition: Finance and M&A

Bar Admission & Education

  • Ontario, 2011
  • Québec, 2010
  • JD, Queen's University, 2009
  • LLB, Université de Montréal, 2008
  • B.Comm., McGill University, 2005